We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

red blood cells via Shutterstock
Stem Cells

Red blood cells grown in a lab to be trialled in humans

A team of researchers across Ireland and the United Kingdom used stem cells to grow red blood cells.

RED BLOOD CELLS grown from stem cells could be trialled in humans within the next three years.

If successful, this would offer an alternative to using donated blood for transfusions.

This method carries a number of risks, such as infection or rejection by the receiver’s body.

A team of researchers from across Ireland and the United Kingdom, led by the Scottish National Blood Transfusion Service, will now receive over €6 million in funding to carry out this next phase of the project, having successful grown red blood cells from stem cells.

The Irish Blood Transfusion Service also took part in the research.

Principal Investigator Professor Marc Turner said producing such a therapy that can be used by humans was a “very significant challenge”

If we can achieve success with this first-in-man clinical study it will be an important step forward to enable populations all over the world to benefit from blood transfusions.

It will also benefit other researchers working on similar cellular therapies.

The funding was awarded to the researchers yesterday by the Wellcome Trust.

Sickle Cell: Ireland’s new disease which affects 400 children and 100 adults >

Read: Here is why your veins look blue >

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.